But we are not--I mean, one of the major recommendations that comes out of this is that we still have not figured out how to leverage the ingenuity and innovation of the pharmaceutical sector of our economy to get involved in developing medical countermeasures to diseases that in some sense are hypothetical.
Lieberman emphasizes the need for pharmaceutical innovation in medical countermeasures.
Share
More from Joe Lieberman
I appreciate the leadership that the Committee is showing, because this really is a threat to our country.
Thanks very much, Mr. Chairman, Ranking Member Stabenow, and members of the Committee.
partisan considerations have absolutely nothing to do with the quest of D.C. citizens for full democracy
You may choose to look the other way, but you can never again say you did not know.
Other voices in this conversation
